Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-020360
Filing Date
2025-06-13
Accepted
2025-06-13 20:14:55
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3145
  Complete submission text file 0001437749-25-020360.txt   4730
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INSULET CORPORATION 600 TECHNOLOGY PARK DRIVE, SUITE 200 BILLERICA MA 01821
Business Address
Dorval Allison (Reporting) CIK: 0001625110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 251048202